| Company Name: |
Suzhou Meishi Biotechnology Co., Ltd.
|
| Tel: |
1173954148q |
| Email: |
meishipharma@126.com |
| Products Intro: |
Product Name:148504-51-2
CAS:148504-51-2
Purity:99% HPLC Package:1G;5G;10G;100G;1KG;
|
| Company Name: |
Nantong QuanYi Biotechnology Co., Ltd
|
| Tel: |
0513-66337626 18051384581 |
| Email: |
sales@chemhifuture.com |
| Products Intro: |
Product Name:Ripisartan
CAS:148504-51-2
Purity:98%HPLC Package:10mg，100mg，500mg，1g，2g，5g，10g，more
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:Ripisartan
CAS:148504-51-2
Purity:98% Package:1mg;5mg;10mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Ripisartan
CAS:148504-51-2
Purity:98.24% Package:1mg/RMB 1330;5mg/RMB 3310;10mg/RMB 4820
|
Ripisartan manufacturers
- Ripisartan
-
- $191.00 / 1mg
-
2024-11-19
- CAS:148504-51-2
- Min. Order:
- Purity: 98.24%
- Supply Ability: 10g
|
| | Ripisartan Basic information |
| Product Name: | Ripisartan | | Synonyms: | UP 269-6;5-Methyl-7-n-propyl-8-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-(1,2,4)-triazolo(1,5-c)pyrimidin-2(3H)-one;Ripisartan;[1,2,4]Triazolo[1,5-c]pyrimidin-2(3H)-one, 5-methyl-7-propyl-8-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | | CAS: | 148504-51-2 | | MF: | C23H22N8O | | MW: | 426.47 | | EINECS: | | | Product Categories: | | | Mol File: | 148504-51-2.mol |  |
| | Ripisartan Chemical Properties |
| | Ripisartan Usage And Synthesis |
| Uses | Ripisartan (UP-2696) is an angiotensin II receptor antagonist. Ripisartan is orally available. Ripisartan binds to angiotensin II receptors, dilates blood vessels, and lowers blood pressure[1]. | | IC 50 | AT2 Receptor | | References | [1] Virone-Oddos A, et al. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Br J Pharmacol. 1997 Feb;120(3):488-94. DOI:10.1038/sj.bjp.0700897 |
| | Ripisartan Preparation Products And Raw materials |
|